RJ

Reena Jain

Active Director Director DIN 10405208
DIN 10405208 First appointment Nov 2023 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Reena Jain

Data last updated:

Reena Jain is a Director at International Perinatal Epidemiology Unit Private Limited (since 2023). The company operates in Research & Development. International Perinatal Epidemiology Unit Private Limited reported revenue of ₹1.10 Cr (FY 2025).

DIN 10405208
Primary Designation Director
Industry Research & Development
First Appointment 25 Nov 2023
Oldest Company Age 5 yrs
Largest company International Perinatal Epidemiology Unit Private Limited · ₹1.10 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Nov 20232021₹1.10 Cr (FY 2025)Active

Board colleagues of Reena Jain

Directorship timeline

Open interactive timeline →
International Perinatal Epidemiology Unit Private Limited
Premium access

Shareholding and investment profile for Reena Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Jain

Reena Jain currently holds 1 directorship: International Perinatal Epidemiology Unit Private Limited (Director, since 25 Nov 2023, revenue ₹1.10 Cr (FY 2025)).

Reena Jain was first appointed on 25 Nov 2023 as Director at International Perinatal Epidemiology Unit Private Limited.

The current boards of Reena Jain's companies include Rohan Agarwal (International Perinatal Epidemiology Unit Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available